EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers

Francesca Tavano iD, Anna Latiano, Orazio Palmieri iD, Domenica Gioffreda, Tiziana Latiano, Annamaria Gentile, Matteo Tardio, Tiziana Pia Latiano, Marco Gentile, Fulvia Terracciano, Francesco Perri iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Francesca Tavano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Endoscopy, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotond…. Hauptthemen laut MEDLINE: Mutation, Pancreatic Neoplasms, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Minister of Health, Italian Minister of Health, Ricerca Corrente program 2022–2024, Division of Gastroenterology, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo (FG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosis of biliopancreatic cancers by the available serum tumor markers, imaging, and histopathological tissue specimen examination remains a challenge. Circulating cell-free DNA derived from matched pairs of secretin-stimulated duodenal fluid (DF) and plasma from 10 patients with biliopancreatic diseases and 8 control subjects was analyzed using AmpliSeq™ HD technology for Ion Torrent Next-Generation Sequencing to evaluate the potential of liquid biopsy with DF in biliopancreatic cancers. The median cfDNA concentration was greater in DF-derived than in plasma-derived samples. A total of 13 variants were detected: 11 vs. 1 were exclusive for DF relative to the plasma source, and 1 was shared between the two body fluids. According to the four-tier systems, 10 clinical tier-I–II (76.9%), 1 tier–III (7.7%), and 2 tier–IV (15.4%) variants were identified. Notably, the 11 tier-I-III variants were exclusively found in DF-derived cfDNA from five patients with biliopancreatic cancers, and were detected in seven genes (KRAS, TP53, BRAF, CDKN2A, RNF43, GNAS, and PIK3CA); 82% of the tier-I-III variants had a low abundance, with a VAF < 6%. The mutational profiling of DF seems to be a reliable and promising tool for identifying cancer-associated alterations in malignant cancers of the biliopancreatic tract.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationPancreatic NeoplasmsHigh-Throughput Nucleotide SequencingHumansMaleFemaleMiddle AgedAgedDuodenumBiomarkers, TumorLiquid BiopsyAdultCell-Free Nucleic AcidsBiliary Tract NeoplasmsGTP-Binding Protein alpha Subunits, GsChromogranins

Stichwörter der Autor:innen

biliopancreatic cancersduodenal fluidliquid biopsymutation profilingsomatic variants

Substanzen

Biomarkers, TumorCell-Free Nucleic AcidsGNAS protein, humanGTP-Binding Protein alpha Subunits, GsChromogranins

Autor:innen und Institutionen

  • Division of Gastroenterology and Endoscopy, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.
  • Department of Surgery, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.
  • Department of Oncology, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.

ORCID-Profile: Francesca Tavano, Orazio Palmieri, Francesco Perri

Förderung

  • Italian Minister of Health
  • Italian Minister of Health, Ricerca Corrente program 2022–2024
  • Division of Gastroenterology, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo (FG)
  • “5 × 1000” voluntary contribution

Zitieren

APA

Tavano, F., Latiano, A., Palmieri, O., Gioffreda, D., Latiano, T., Gentile, A., Tardio, M., Latiano, T. P., Gentile, M., Terracciano, F., & Perri, F. (2024). Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158436

Vancouver

Tavano F, Latiano A, Palmieri O, Gioffreda D, Latiano T, Gentile A, et al. Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158436

BibTeX
@article{Tavano2024,
  author = {Tavano, Francesca and Latiano, Anna and Palmieri, Orazio and Gioffreda, Domenica and Latiano, Tiziana and Gentile, Annamaria and Tardio, Matteo and Latiano, Tiziana Pia and Gentile, Marco and Terracciano, Fulvia and Perri, Francesco},
  title = {Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158436}
}
Kostenlos starten →